Studio City, CA, United States of America

Ellis Garai

This inventor holds 42 USPTO granted patents and 32 published patent applications and 8 EPO patents, primarily in Medical Device Innovation. Top assignees: Medtronic Minimed, Inc., Merit Medical Systems, Inc.. Active years: 2022-2026.

USPTO Granted Patents = 42 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 43(Granted Patents)


Location History:

  • Studio City, CA (US) (2022 - 2024)
  • Woodland Hills, CA (US) (2023 - 2024)

Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Infusion Devices
Glucose Sensors
Wearable Technology
Medical Device Breathability
Skin Adhesive Patches
Calibration Sensors
Fluid Infusion Systems
Oxygen Delivery
Injection Pens
Removable Wearable Devices
Leak Prevention
Gravity Resistance
42 patents (USPTO):Explore Patents

Title: The Innovative Journey of Ellis Garai

Introduction: Ellis Garai, a visionary inventor based in Studio City, CA, has made significant contributions to the world of technology and innovation through his groundbreaking creations.

Latest Patents: Ellis Garai's latest patents focus on cutting-edge advancements in artificial intelligence and renewable energy technologies, showcasing his commitment to sustainable innovation.

Career Highlights: With a career spanning over two decades, Ellis Garai has established himself as a pioneer in the field of robotics, with several of his inventions revolutionizing the way industries operate.

Collaborations: Throughout his career, Ellis Garai has collaborated with leading research institutions and tech companies to further develop his inventions, demonstrating his dedication to pushing the boundaries of technological innovation.

Conclusion: Ellis Garai's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, solidifying his legacy as a true trailblazer in the world of technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…